Zeitschriftenartikel (6)

  1. 2013
    Witt, R. M.; Hecht, M. L.; Pazyra-Murphy, M. F.; Cohen, S. M.; Noti, C.; van Kuppevelt, T. H.; Fuller, M.; Chan, J. A.; Hopwood, J. J.; Seeberger, P. H. et al.; Segal, R. A.: Heparan Sulfate Proteoglycans Containing a Glypican 5 Core and 2-O-Sulfo-iduronic Acid Function as Sonic Hedgehog Co-receptors to Promote Proliferation. Journal of Biological Chemistry 288 (36), S. 26275 - 26288 (2013)
  2. 2011
    Adibekian, A.; Stallforth, P.; Hecht, M. L.; Werz, D. B.; Gagneux, P.; Seeberger, P. H.: Comparative bioinformatics analysis of the mammalian and bacterial glycomes. Chemical Science 2 (2), S. 337 - 344 (2011)
  3. Zeitschriftenartikel
    Horlacher, T.; Noti, C.; de Paz, J. L.; Bindschädler, P.; Hecht, M. L.; Smith, D. F.; Fukuda, M. N.; Seeberger, P. H.: Characterization of Annexin A1 Glycan Binding Reveals Binding to Highly Sulfated Glycans with Preference for Highly Sulfated Heparan Sulfate and Heparin. Biochemistry 50 (13), S. 2650 - 2659 (2011)
  4. Zeitschriftenartikel
    Oberli, M. A.; Hecht, M. L.; Bindschädler, P.; Adibekian, A.; Adam, T.; Seeberger, P. H.: A Possible Oligosaccharide-Conjugate Vaccine Candidate for Clostridium difficile Is Antigenic and Immunogenic. Chemistry & Biology 18 (5), S. 580 - 588 (2011)
  5. 2010
    Hecht, M. L.; Tsai, Y. H.; Liu, X. Y.; Wolfrum, C.; Seeberger, P. H.: Synthetic Inositol Phosphoglycans Related to GPI Lack Insulin-Mimetic Activity. ACS Chemical Biology 5 (11), S. 1075 - 1086 (2010)
  6. 2009
    Hecht, M. L.; Stallforth, P.; Varón Silva, D.; Adibekian, A.; Seeberger, P. H.: Recent advances in carbohydrate-based vaccines. Current Opinion in Chemical Biology 13 (3), S. 354 - 359 (2009)

Hochschulschrift - Doktorarbeit (1)

  1. 2010
    Hochschulschrift - Doktorarbeit
    Hecht, M.-L.: Structure-activity relationships of complex carbohydrates. Dissertation, ETH, Zürich (2010)

Patent (1)

  1. 2012
    Seeberger, P. H.; Oberli, M.; Hecht, M.-L.: Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccharide PS-II, methods of synthesis and uses thereof, in particular as a vaccine. EP2683401 (2012)
loading content
Zur Redakteursansicht